[CRL] Charles River Laboratories International, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Biotechnology: Commercial Physical & Biological Resarch

Market Capitalization:

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 75.72 Change: 1.37 (1.84%)
Ext. hours: Change: 0 (0%)

chart CRL

Refresh chart

Strongest Trends Summary For CRL

CRL is in the long-term up 86% in 5 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Charles River Laboratories International, Inc., together with its subsidiaries, provides research models and associated services, and outsourced preclinical services to accelerate the drug discovery and development process. It operates through two segments, Research Models and Services (RMS), and Preclinical Services (PCS). The RMS segment produces and sells research model strains, principally genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also offers a range of services to assist customers in the drug discovery and development process, which include genetically engineered models and services, insourcing solutions, discovery research services, and research animal diagnostic services; endotoxin and microbial detection products and services; and avian vaccine products and services. The PCS segment provides preclinical services, including in vivo and in vitro studies, supporting laboratory services, and strategic preclinical consulting and program manage

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -6.09% Sales Growth - Q/Q-2.77% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA6.9% ROE18.39% ROI8.26%
Current Ratio2.27 Quick Ratio1.95 Long Term Debt/Equity2.2 Debt Ratio0.39
Gross Margin36.67% Operating Margin13.72% Net Profit Margin9.67% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-63.73 M Cash From Investing Activities-36.49 M Cash From Operating Activities96.68 M Gross Profit132.78 M
Net Profit48.51 M Operating Profit55.73 M Total Assets1.89 B Total Current Assets629.65 M
Total Current Liabilities276.53 M Total Debt772.77 M Total Liabilities1.18 B Total Revenue339.57 M
Technical Data
High 52 week148.55 Low 52 week104.82 Last close132.6 Last change-1.63%
RSI44.11 Average true range4.13 Beta0.74 Volume208.32 K
Simple moving average 20 days-2.2% Simple moving average 50 days-1.84% Simple moving average 200 days0.51%
Performance Data
Performance Week-0.39% Performance Month-2.86% Performance Quart-2.89% Performance Half5.72%
Performance Year8.46% Performance Year-to-date17.16% Volatility daily2.02% Volatility weekly4.52%
Volatility monthly9.26% Volatility yearly32.08% Relative Volume241.93% Average Volume337.28 K
New High New Low

News

2019-10-16 16:30:00 | Charles River Laboratories Demonstrates Industry-Leading Research at Neuroscience 2019

2019-10-15 12:35:55 | Is Charles River Laboratories International Inc. CRL Going To Burn These Hedge Funds ??

2019-10-09 09:18:34 | Calculating The Fair Value Of Charles River Laboratories International, Inc. NYSE:CRL

2019-10-08 10:36:02 | LabCorp LH Names Two Leaders for Major Business Wings

2019-10-03 08:00:00 | Charles River Laboratories Joins Dementia Consortium, Reaffirms Commitment to Neuroscience Research

2019-10-01 08:00:00 | Charles River Laboratories Adds Virginia M. Wilson to Board of Directors

2019-09-19 10:44:16 | Need To Know: Charles River Laboratories International, Inc. NYSE:CRL Insiders Have Been Selling Shares

2019-09-09 08:00:00 | Charles River Laboratories Announces Updates to Microbial Solutions Product Portfolio

2019-09-05 16:30:00 | Charles River Laboratories to Host 3rd Annual World Congress

2019-09-04 09:00:01 | What Makes Charles River CRL a New Buy Stock

2019-09-03 16:30:00 | Charles River Laboratories to Present at Baird and Morgan Stanley Investor Conferences

2019-08-30 07:45:58 | How Good Is Charles River Laboratories International, Inc. NYSE:CRL, When It Comes To ROE?

2019-08-12 10:14:25 | Is Charles River Laboratories International NYSE:CRL A Risky Investment?

2019-08-02 03:40:30 | Edited Transcript of CRL earnings conference call or presentation 31-Jul-19 12:30pm GMT

2019-08-01 02:17:51 | Blue-blooded crabs at heart of pharma dispute on drug testing

2019-08-01 02:00:00 | FOCUS-Blue-blooded crabs at heart of pharma dispute on drug testing

2019-07-31 19:23:38 | Charles River Laboratories International Inc CRL Q2 2019 Earnings Call Transcript

2019-07-31 08:25:12 | Charles River Laboratories CRL Q2 Earnings Beat Estimates

2019-07-31 07:00:00 | Charles River Laboratories Announces Second-Quarter 2019 Results

2019-07-30 11:45:03 | Healthcare Stock Q2 Earnings Due on Jul 31: HUM, AMED & More

2019-07-24 10:32:02 | Earnings Preview: Charles River Laboratories CRL Q2 Earnings Expected to Decline

2019-07-24 07:24:50 | Here's What We Think About Charles River Laboratories International, Inc.'s NYSE:CRL CEO Pay

2019-07-16 16:15:00 | Charles River Laboratories Schedules Second-Quarter 2019 Earnings Release and Conference Call

2019-07-09 08:00:00 | Charles River Laboratories to Open Flexible Vivarium Space for Clients in South San Francisco

2019-06-20 13:33:16 | Is Charles River Laboratories International Inc. CRL A Good Stock To Buy?

2019-06-14 15:02:00 | Don't Jump Into Charles River Labs Just Yet

2019-06-10 08:02:27 | See what the IHS Markit Score report has to say about Charles River Laboratories International Inc.

2019-06-03 08:30:00 | Charles River Laboratories to Present at Jefferies and Goldman Sachs Investor Conferences

2019-05-30 08:03:19 | See what the IHS Markit Score report has to say about Charles River Laboratories International Inc.

2019-05-28 08:03:18 | See what the IHS Markit Score report has to say about Charles River Laboratories International Inc.

2019-05-16 08:00:00 | Charles River Laboratories Invests in Resero Analytics™

2019-05-13 10:19:47 | How Do Analysts See Charles River Laboratories International, Inc. NYSE:CRL Performing Over The Next Year?

2019-05-07 17:00:26 | Edited Transcript of CRL earnings conference call or presentation 7-May-19 12:30pm GMT

2019-05-07 16:13:18 | Medical Stock Pummeled On China Trade Worries — Wiping Out Earnings Beat

2019-05-07 15:23:43 | Charles River Laboratories International Inc CRL Q1 2019 Earnings Call Transcript

2019-05-07 08:15:12 | Charles River Laboratories CRL Beats Q1 Earnings and Revenue Estimates

2019-05-07 08:01:46 | See what the IHS Markit Score report has to say about Charles River Laboratories International Inc.

2019-05-07 07:11:34 | Charles River: 1Q Earnings Snapshot

2019-05-07 07:00:00 | Charles River Laboratories Announces First-Quarter 2019 Results

2019-05-03 15:18:56 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL

2019-05-01 20:55:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL

2019-04-30 14:39:45 | Charles River Labs says its biotech, pharma clients' data was hacked

2019-04-30 10:32:02 | Charles River Laboratories CRL Q1 Earnings Preview: What's in the Cards?

2019-04-29 07:00:00 | Charles River Laboratories Completes the Acquisition of Citoxlab

2019-04-22 13:12:40 | Were Hedge Funds Right About Piling Into Charles River Laboratories International CRL?

2019-04-22 10:42:20 | Here's How P/E Ratios Can Help Us Understand Charles River Laboratories International, Inc. NYSE:CRL

2019-04-12 11:52:03 | Top Ranked Growth Stocks to Buy for April 12th

2019-04-12 10:32:02 | Teladoc's Partnership to Form Pediatric Telehealth Platform

2019-04-11 08:30:00 | Charles River Laboratories Schedules First-Quarter 2019 Earnings Release and Conference Call

2019-04-09 10:48:34 | See what the IHS Markit Score report has to say about Charles River Laboratories International Inc.